{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:05:38Z","timestamp":1784883938184,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017680","name":"Colleges and Universities in Hebei Province Science and Technology Research Project","doi-asserted-by":"crossref","award":["ZD2022078"],"award-info":[{"award-number":["ZD2022078"]}],"id":[{"id":"10.13039\/501100017680","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hebei Government-funded Outstanding Clinical Medical Talents Project","award":["ZF2023230"],"award-info":[{"award-number":["ZF2023230"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56207-z","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T06:54:35Z","timestamp":1781420075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["POTEF upregulation drives hepatocellular carcinoma progression via oncogenic signaling and immune modulation"],"prefix":"10.1038","volume":"16","author":[{"given":"Zan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"56207_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00406-z","volume":"10","author":"H Peng","year":"2022","unstructured":"Peng, H., Zhu, E. & Zhang, Y. Advances of cancer-associated fibroblasts in liver cancer. Biomark. Res. 10, 59. https:\/\/doi.org\/10.1186\/s40364-022-00406-z (2022).","journal-title":"Biomark. Res."},{"key":"56207_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188621","volume":"1876","author":"KJ Mintz","year":"2021","unstructured":"Mintz, K. J. & Leblanc, R. M. The use of nanotechnology to combat liver cancer: Progress and perspectives. Biochim. Biophys. Acta (BBA) - Rev. Cancer 1876, 188621. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188621 (2021).","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"56207_CR3","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo, W. L. et al. Impact of middle hepatic vein resection during hemihepatectomy on surgical outcomes and long-term prognosis in hepatocellular carcinoma: A retrospective study. J. Hepatocell. Carcinoma 12, 2681\u20132692. https:\/\/doi.org\/10.2147\/JHC.S556306 (2025).","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"2","key":"56207_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.474","volume":"5","author":"X Luo","year":"2024","unstructured":"Luo, X. et al. Hepatocellular carcinoma: Signaling pathways, targeted therapy, and immunotherapy. MedComm 5(2), e474. https:\/\/doi.org\/10.1002\/mco2.474 (2024).","journal-title":"MedComm"},{"key":"56207_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1714314","volume":"17","author":"J Li","year":"2026","unstructured":"Li, J. et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: Implications for postoperative recurrence risk. Front. Immunol. 17, 1714314. https:\/\/doi.org\/10.3389\/fimmu.2026.1714314 (2026).","journal-title":"Front. Immunol."},{"key":"56207_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41698-025-01213-z","volume":"10","author":"K Tang","year":"2025","unstructured":"Tang, K., Han, L., Li, J. & Li, K. Machine learning-driven comprehensive profiling of tumor heterogeneity and sialylation in hepatocellular carcinoma. NPJ Precis. Oncol. 10, 13. https:\/\/doi.org\/10.1038\/s41698-025-01213-z (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"56207_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100790","volume":"59","author":"P Icard","year":"2021","unstructured":"Icard, P. et al. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma. Drug Resist. Updat. 59, 100790. https:\/\/doi.org\/10.1016\/j.drup.2021.100790 (2021).","journal-title":"Drug Resist. Updat."},{"key":"56207_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jhep.2024.01.018","volume":"80","author":"G Cabibbo","year":"2024","unstructured":"Cabibbo, G. et al. Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice. J. Hepatol. 80, 957\u2013966. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.018 (2024).","journal-title":"J. Hepatol."},{"key":"56207_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/1878-0261.13568","volume":"18","author":"A Martinez-Lopez","year":"2024","unstructured":"Martinez-Lopez, A. et al. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1. Mol. Oncol. 18, 620\u2013640. https:\/\/doi.org\/10.1002\/1878-0261.13568 (2024).","journal-title":"Mol. Oncol."},{"key":"56207_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10476","volume":"8","author":"S Qazi","year":"2022","unstructured":"Qazi, S. et al. BESFA: Bioinformatics based evolutionary, structural & functional analysis of prostrate, placenta, ovary, testis, and embryo (POTE) paralogs. Heliyon 8, e10476. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10476 (2022).","journal-title":"Heliyon"},{"key":"56207_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A., Meyer, T., Sapisochin, G., Salem, R. & Saborowski, A. Hepatocellular carcinoma. Lancet 400, 1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4 (2022).","journal-title":"Lancet"},{"key":"56207_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.997747","volume":"9","author":"RI Mohd Yunos","year":"2022","unstructured":"Mohd Yunos, R. I. et al. Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations. Front. Mol. Biosci. 9, 997747. https:\/\/doi.org\/10.3389\/fmolb.2022.997747 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"56207_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-021-00566-1","volume":"7","author":"Y Kasahara","year":"2021","unstructured":"Kasahara, Y. et al. Primate-specific POTE-actin gene could play a role in human folliculogenesis by controlling the proliferation of granulosa cells. Cell. Death Discov. 7, 186. https:\/\/doi.org\/10.1038\/s41420-021-00566-1 (2021).","journal-title":"Cell. Death Discov"},{"key":"56207_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2046-7","volume":"10","author":"Z Shen","year":"2019","unstructured":"Shen, Z. et al. POTEE drives colorectal cancer development via regulating SPHK1\/p65 signaling. Cell Death Dis. 10, 863. https:\/\/doi.org\/10.1038\/s41419-019-2046-7 (2019).","journal-title":"Cell Death Dis."},{"key":"56207_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28227501","author":"M Jayathirtha","year":"2023","unstructured":"Jayathirtha, M. et al. Two-dimensional-PAGE coupled with nLC-MS\/MS-based identification of differentially expressed proteins and tumorigenic pathways in MCF7 breast cancer cells transfected for JTB protein silencing. Molecules https:\/\/doi.org\/10.3390\/molecules28227501 (2023).","journal-title":"Molecules"},{"key":"56207_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ccell.2024.12.002","volume":"43","author":"K Ellrott","year":"2025","unstructured":"Ellrott, K. et al. Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets. Cancer Cell 43, 195-212 e111. https:\/\/doi.org\/10.1016\/j.ccell.2024.12.002 (2025).","journal-title":"Cancer Cell"},{"key":"56207_CR17","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2026.5729","author":"XM Chen","year":"2026","unstructured":"Chen, X. M. et al. ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int. J. Mol. Med. https:\/\/doi.org\/10.3892\/ijmm.2026.5729 (2026).","journal-title":"Int. J. Mol. Med."},{"key":"56207_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581098","volume":"16","author":"D Xie","year":"2025","unstructured":"Xie, D. et al. Immune microenvironment and immunotherapy in hepatocellular carcinoma: Mechanisms and advances. Front. Immunol. 16, 1581098. https:\/\/doi.org\/10.3389\/fimmu.2025.1581098 (2025).","journal-title":"Front. Immunol."},{"key":"56207_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218527","volume":"651","author":"J Sun","year":"2026","unstructured":"Sun, J., Yang, F., Li, Y., Li, S. & Song, J. Neutrophil polarization landscapes in HCC: From immunosuppressive niches to antitumor immunity resuscitation. Cancer Lett. 651, 218527. https:\/\/doi.org\/10.1016\/j.canlet.2026.218527 (2026).","journal-title":"Cancer Lett."},{"key":"56207_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 7, 6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"56207_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct. Target. Ther. 9, 132. https:\/\/doi.org\/10.1038\/s41392-024-01823-2 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"56207_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35567-1","volume":"8","author":"CJ Barger","year":"2018","unstructured":"Barger, C. J. et al. Expression of the POTE gene family in human ovarian cancer. Sci. Rep. 8, 17136. https:\/\/doi.org\/10.1038\/s41598-018-35567-1 (2018).","journal-title":"Sci. Rep."},{"key":"56207_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/biof.1640","volume":"46","author":"Q Hao","year":"2020","unstructured":"Hao, Q. et al. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K\/Akt\/GSK-3beta\/beta-catenin signaling. Biofactors 46, 685\u2013692. https:\/\/doi.org\/10.1002\/biof.1640 (2020).","journal-title":"Biofactors"},{"key":"56207_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05022-z","volume":"22","author":"Q Yang","year":"2024","unstructured":"Yang, Q. et al. Deciphering the Omicron variant: Integrated omics analysis reveals critical biomarkers and pathophysiological pathways. J. Transl. Med. 22, 219. https:\/\/doi.org\/10.1186\/s12967-024-05022-z (2024).","journal-title":"J. Transl. Med."},{"key":"56207_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cellimm.2018.10.010","volume":"335","author":"U Vekariya","year":"2019","unstructured":"Vekariya, U., Rawat, K., Saxena, R. & Tripathi, R. K. Identification of MPhi specific POTEE expression: Its role in mTORC2 activation via protein-protein interaction in TAMs. Cell. Immunol. 335, 30\u201340. https:\/\/doi.org\/10.1016\/j.cellimm.2018.10.010 (2019).","journal-title":"Cell. Immunol."},{"key":"56207_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401032","volume":"13","author":"P Barros da Silva","year":"2024","unstructured":"Barros da Silva, P. et al. Tunable hybrid hydrogels of alginate and cell-derived dECM to study the impact of matrix alterations on epithelial-to-mesenchymal transition. Adv. Healthc. Mater. 13, e2401032. https:\/\/doi.org\/10.1002\/adhm.202401032 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"56207_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.devcel.2021.02.028","volume":"56","author":"Y Katsuno","year":"2021","unstructured":"Katsuno, Y. & Derynck, R. Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-beta family. Dev. Cell. 56, 726\u2013746. https:\/\/doi.org\/10.1016\/j.devcel.2021.02.028 (2021).","journal-title":"Dev. Cell."},{"key":"56207_CR28","doi-asserted-by":"publisher","DOI":"10.34133\/bmef.0144","volume":"6","author":"R Naserkhaki","year":"2025","unstructured":"Naserkhaki, R. et al. Revisiting treatment strategies: Addressing epithelial-to-mesenchymal transition-induced resistance in hepatocellular carcinoma. BME Front. 6, 0144. https:\/\/doi.org\/10.34133\/bmef.0144 (2025).","journal-title":"BME Front."},{"key":"56207_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: From bench to bedside. Exp. Hematol. Oncol. 13, 72. https:\/\/doi.org\/10.1186\/s40164-024-00539-x (2024).","journal-title":"Exp. Hematol. Oncol."},{"key":"56207_CR30","doi-asserted-by":"publisher","DOI":"10.34133\/bmr.0025","volume":"28","author":"MM Chowdhury","year":"2024","unstructured":"Chowdhury, M. M. et al. Superior induced pluripotent stem cell generation through Phactr3-driven mechanomodulation of both early and late phases of cell reprogramming. Biomater. Res. 28, 0025. https:\/\/doi.org\/10.34133\/bmr.0025 (2024).","journal-title":"Biomater. Res."},{"key":"56207_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.stemcr.2018.12.008","volume":"12","author":"H Kagawa","year":"2019","unstructured":"Kagawa, H. et al. OVOL1 influences the determination and expansion of iPSC reprogramming intermediates. Stem Cell Reports. 12, 319\u2013332. https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.008 (2019).","journal-title":"Stem Cell Reports."},{"key":"56207_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-021-03525-z","volume":"594","author":"DJ Flanagan","year":"2021","unstructured":"Flanagan, D. J. et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594, 430\u2013435. https:\/\/doi.org\/10.1038\/s41586-021-03525-z (2021).","journal-title":"Nature"},{"key":"56207_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05239-6","volume":"6","author":"P Potalitsyn","year":"2023","unstructured":"Potalitsyn, P. et al. Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2. Commun. Biol. 6, 863. https:\/\/doi.org\/10.1038\/s42003-023-05239-6 (2023).","journal-title":"Commun. Biol."},{"key":"56207_CR34","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.7150\/ijbs.91877","volume":"20","author":"Y Meng","year":"2024","unstructured":"Meng, Y. et al. Myeloid cell-expressed MNDA enhances M2 polarization to facilitate the metastasis of hepatocellular carcinoma. Int. J. Biol. Sci. 20, 2814\u20132832. https:\/\/doi.org\/10.7150\/ijbs.91877 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"56207_CR35","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1016\/j.apsb.2024.05.001","volume":"14","author":"D Han","year":"2024","unstructured":"Han, D. et al. Reprogramming tumor-associated macrophages and inhibiting tumor neovascularization by targeting MANF-HSF1-HSP70-1 pathway: An effective treatment for hepatocellular carcinoma. Acta Pharm. Sin. B. 14, 4396\u20134412. https:\/\/doi.org\/10.1016\/j.apsb.2024.05.001 (2024).","journal-title":"Acta Pharm. Sin. B."},{"key":"56207_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04716-0","volume":"21","author":"J Huang","year":"2023","unstructured":"Huang, J., Wu, Q., Geller, D. A. & Yan, Y. Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC). J. Transl. Med. 21, 815. https:\/\/doi.org\/10.1186\/s12967-023-04716-0 (2023).","journal-title":"J. Transl. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56207-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56207-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56207-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:42:02Z","timestamp":1784882522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56207-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56207"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56207-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23212"}}